Deformational plagiocephaly and brachycephaly, on the rise since 1992, were corrected in 77.1% of infants with conservative repositioning therapy as a first-line treatment, according to a study.

Zzoma is an FDA-cleared positional therapy device indicated for the first-line treatment of mild to moderate positional OSA, or for patients with CPAP intolerance. By promoting side sleeping ...